Resistance Exercise May Reduce Depressive Symptoms in Adults

Share this content:
Resistance Exercise May Reduce Depressive Symptoms in Adults
Resistance Exercise May Reduce Depressive Symptoms in Adults

FRIDAY, May 11, 2018 (HealthDay News) -- Resistance exercise training (RET) is associated with reduced depressive symptoms among adults, according to a meta-analysis published online May 9 in JAMA Psychiatry.

Brett R. Gordon, from the University of Limerick in Ireland, and colleagues examined the correlation of efficacy of RET with depressive symptoms using data from 33 randomized clinical trials involving 1,877 participants. The trials used validated measures of depressive symptoms, which were assessed at baseline and mid- and/or post-intervention. A total of 947 participants were randomized to RET and 930 to a nonactive control condition.

The researchers observed a significant reduction in depressive symptoms with RET, with a moderate-sized mean effect Δ of 0.66. There was considerable heterogeneity, and 32.9 percent of the observed variance was accounted for by sampling error. There was a number needed to treat of four. There were no significant correlations for total volume of prescribed RET, participant health status, and strength improvements with the antidepressant effect of RET. Randomized clinical trials with blinded allocation and/or assessment had smaller reductions in depressive symptoms.

"Resistance exercise training significantly reduced depressive symptoms among adults regardless of health status, total prescribed volume of RET, or significant improvements in strength," the authors write. "Better-quality randomized clinical trials blinding both allocation and assessment and comparing RET with other empirically supported treatments for depressive symptoms are needed."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »